United Kingdom · 
Who invested in Nucleome Therapeutics?
Nucleome Therapeutics's investors include Creative Destruction Lab and Oxford Science Enterprises.
20232024
$42MSeries A$24MSeries A
United Kingdom · Series A startup
Who invested in Nucleome Therapeutics
Funding summaryUpdated 26 Oct 2026
$66Mraised across 2 rounds since 2022, from 2 sources
$42MSeries A$24MSeries A
- Latest round
- Series A, $24MJul 2024
- Biggest round
- $42MSeries A · Oct 2022
- Investors
- 2
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $42M Oct 2022
- Biggest round
- $42M Series A · Oct 2022
- Between rounds
- 21 months from the last two
The rounds
- Jul 2024Series A$24M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Oct 2022
Funding filed with regulators
Nucleome Therapeutics filed one raise, $24M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jul 2024$24MUK share allotment
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nucleome Therapeutics
How much has Nucleome Therapeutics raised?
Nucleome Therapeutics has raised $66M across 2 rounds since 2022.
When did Nucleome Therapeutics last raise?
Nucleome Therapeutics's most recent round was a Series A of $24M in Jul 2024.
What was Nucleome Therapeutics's biggest round?
Nucleome Therapeutics's largest round on record is $42M (Series A), in Oct 2022.
Who backed Nucleome Therapeutics first?
Nucleome Therapeutics's first round on record, in Oct 2022, was backed by Creative Destruction Lab and Oxford Science Enterprises.
What stage is Nucleome Therapeutics at?
Nucleome Therapeutics's latest named round is a Series A, in Jul 2024.
Where is Nucleome Therapeutics based?
Nucleome Therapeutics is based in the United Kingdom.
Companies like Nucleome Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.